Sep 18, 2020

Committed to a Positive and Lasting Impact: The Engelstad Foundation

Samuel Cheshier, MD, PhD, and the Neurologic Cancers Center team at Huntsman Cancer Institute are working to find better treatments for brain cancer, particularly pediatric brain cancer. Many primary brain tumors are incurable from the start, and currently, none are curable once they recur. The need for novel, effective therapies is critical. In 2020, the Engelstad Foundation funded a $100,000 grant at HCI to study a potential immunotherapy treatment for pediatric brain tumors.

May 27, 2020

Utah Researcher Awarded Prestigious Grant to Study New Ways to Detect Brain Tumors

Hunter Underhill, MD, PhD, a Huntsman Cancer Institute brain cancer researcher and assistant professor of pediatrics at the University of Utah, was awarded a special National Cancer Institute grant to advance his research in brain tumor detection. Underhill will pursue new ways to detect glioblastoma, a type of aggressive and deadly brain tumor.

May 07, 2020

Proton Accelerator Arrives at Huntsman Cancer Institute

Construction at the Senator Orrin G. Hatch Center for Proton Therapy at Huntsman Cancer Institute is well underway. On March 28, a 15-ton proton accelerator arrived and was installed at the future center. This marks a major milestone for the project slated for a December 2020 debut.

Jan 16, 2020

Talks with Docs: Sheri Holmen, PhD

Sheri Holmen, PhD, wished to make an impact on the lives of people experiencing cancer and found that becoming a researcher would allow her that and more. When she's not in her lab, Dr. Holmen will often spend time with her children in their many athletic activities, which led her to become nationally certified to officiate swim competitions. Learn this and more in this edition of Talks with Docs.

Jan 13, 2020

Huntsman Cancer Institute Translational Scholars: Randy Jensen, MD, PhD

Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Randy Jensen, MD, PhD, was recently honored with a Huntsman Translational Scholar award.

May 14, 2019

Pushing Up A Hill

Patient and Huntsman Hero Dan Nelson set out to ride the 30-mile segment of the Huntsman 140 in spite of a terminal brain cancer diagnosis. When Dan wasn't sure he could make it up the last hill, his #DanStrong team of family and friends was there to push him to the top. In the hardest of times, Dan and his wife Dianne have never been alone.

Mar 22, 2019

“What Can I Do With My New Normal?” Positivity and Gratitude Guide Matt Pond’s Life after Cancer

Matt Pond was diagnosed at 35 with a brain tumor that had a 1% survival rate. After life-saving surgery at Huntsman Cancer Institute, Matt relearned how to walk and speak. He learned to read and write again—this time with his left hand instead of his dominant right. Now Matt shares his story of resilience with hopes of inspiring others to remain strong through their life's challenges.

Mar 01, 2019

Breaking Ground for Proton Therapy

When construction is complete in 2020, Huntsman Cancer Institute will implement the latest advance in proton therapy, called intensity-modulated proton therapy. Proton therapy is the favored approach for many tumors in and around vital structures such as the spinal cord and brain stem. It is also the preferred treatment for certain childhood cancers. We are committed to bringing cutting-edge care to our patients, and proton therapy will be the next step in that promise.